Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer

NCT03175016 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer Liver Metastasis

Interventions

PROCEDURE: TACE
DRUG: Irinotecan
DEVICE: eluting-bead

Sponsor

Tianjin Medical University Cancer Institute and Hospital